Skip to content
← Full study record

NCT00553202 · OUTCOME

Cumulative Incidence of NK Cell Reconstitution

Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia · Source last updated 2020-04-16

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
NUMBER
Unit
Percentage of participants
Interval / dispersion
95% Confidence Interval
Time frame
At 5 years from HSCT date

What was measured

Cumulative incidence of successful reconstitution to donor level is calculated.

Analysis population: Patients without completion of planned therapy (n=68) or without NK cell status (n=38) are excluded from analyses of TExp

Groups in this outcome

Treatment (Chemotherapy and Allogeneic SCT)

All Patients

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Treatment (Chemotherapy and Allogeneic SCT)52

Reported measurements

Source class 1
Values in Percentage of participants · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Treatment (Chemotherapy and Allogeneic SCT)48.1Not reported33.861.0Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        33.8
        upper Limit
        61.0
        value
        48.1
denoms
  1. counts
    1. group Id
      OG000
      value
      52
    units
    Participants
description
Cumulative incidence of successful reconstitution to donor level is calculated.
dispersion Type
95% Confidence Interval
groups
  1. description
    All Patients
    id
    OG000
    title
    Treatment (Chemotherapy and Allogeneic SCT)
param Type
NUMBER
population Description
Patients without completion of planned therapy (n=68) or without NK cell status (n=38) are excluded from analyses of TExp
reporting Status
POSTED
time Frame
At 5 years from HSCT date
title
Cumulative Incidence of NK Cell Reconstitution
type
PRIMARY
unit Of Measure
Percentage of participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice